View Single Post
Old 12-01-2009, 01:04 PM
Mslday's Avatar
Mslday Mslday is offline
Member
 
Join Date: Aug 2008
Posts: 409
15 yr Member
Mslday Mslday is offline
Member
Mslday's Avatar
 
Join Date: Aug 2008
Posts: 409
15 yr Member
Default

Quote:
Originally Posted by CRPSbe View Post
Yep I did.

I am weary of any kind of study done on a mere 10 patients, though, like in this case. They say the results are promising, but I mean... how far along is their RSD? Are they newly diagnosed cases with mild RSD? Do they have a severe form? Are they 10- or 20-year RSD sufferers for whom nothing has worked much or were they quickly diagnosed? Knowing what patients participated, and what their RSD is like is valuable information, and something they should take into consideration more when doing studies like these.
Yes, lots of good questions but I don't think it should be dismissed just because it is a small study. The authors concluded that the results are encouraging and suggest that magnesium IV as a treatment in CRPS 1 should be further explored in a large size formal trial design.

Personally I'm happy to see something being done regardless of the size of the study. A substance such as magnesium with far fewer side effects than many other drugs is attractive to me. The authors also stated;
Quote:
Previous research showed that intravenous magnesium leads to a decrease in pain in both acute and chronic pain patients.
It's very encouraging to see an organization such as TREND supporting research for CRPS. Perhaps one day they will gain enough momentum and get more funding for further research.

Thanks for sharing

MsL
Mslday is offline   Reply With QuoteReply With Quote